Andere Sprachen Granules India Limited

Aktien

A14QQF

INE101D01020

GRANULES

Verzögert Bombay S.E. Andere Börsenplätze 09:13:38 29.05.2024			% 5 Tage	% 1. Jan.
430,1 ^INR	-0,97 %		+0,77 %	+6,09 %

15.05.	Transcript : Granules India Limited, Q4 2024 Earnings Call, May 15, 2024
15.05.	Granules India verzeichnet Umsatzrückgang im 4. Quartal aufgrund schwacher Paracetamolverkäufe und Preisverfall	RE

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Granules India Posts Decline in Fiscal Q4 Consolidated Net Profit, Revenue	15.05.
Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion	15.05.
Granules India Limited Recommends Final Dividend for the Financial Year 2023-24, Payable on July 30, 2024	15.05.
Granules India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	15.05.
Granules India Limited Reports Earnings Results for the Full Year Ended March 31, 2024	15.05.
Granules India : ANDA Approval for Colchicine Capsules 0.6 mg	30.04.
Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares	30.04.
Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit	15.04.
Granules India Unit Gets VAI Status for Virginia Facility	03.04.
Granules India Limited Announces Appointment of Directors	02.04.
Granules India Limited Announces Cessation of Arun Rao Akinepally as Independent Director	29.03.
Granules India Limited Announces Appointment of Sethu Madhavan Sankaran as Senior Vice President - Api Manufacturing & Operations	29.03.
Granules India Limited Appoints Atul Dhavle as Chief Human Resources Officer	11.03.
Granules India Limited Announces That J. Shravan Reddy Shall Cease to Be Senior Vice President & Head- API Manufacturing	05.03.
Paracetamol maker Granules India posts marginal rise in Q3 profit	23.01.
Granules India's Posts Gains in Fiscal Q3 Consolidated Net Profit	23.01.
Granules India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	23.01.
Granules Pharmaceuticals Unit's Virginia Facility Gets Five Observations from US FDA	18.12.
Granules India Gets US FDA Nod for Pantoprazole Sodium Delayed-Release Tablets	13.12.
Granules India Limited Receives ANDA Approval for Pantoprazole Sodium Delayed-Release Tablets	13.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Granules India Limited

Aktien

A14QQF

INE101D01020

GRANULES

Andere Sprachen

Filter